Stage IIB Ovarian Cancer AJCC v8: Clinical Trials

4 trials for Stage IIB Ovarian Cancer AJCC v8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Stage IIB Ovarian Cancer AJCC v8: new trials by email Literature Review of Stage IIB Ovarian Cancer AJCC v8 trials Research Report on Stage IIB Ovarian Cancer AJCC v8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Alpha-type-1 Polarized Dendritic Cells, Autologous Natural Killer Cell-like CTLs - Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8
Phase 1 / Phase 2WithdrawnRoswell Park Cancer Institute2023-12-152023-11-22
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Medical Device Usage and Evaluation, Quality-of-Life Assessment, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Active not recruitingUniversity of Southern California1732021-11-242026-10-05
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
CompletedCity of Hope Medical Center222020-08-112026-10-14
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Chemotherapy, Functional Assessment, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Active not recruitingSWOG Cancer Research Network13362019-05-142026-10-02

Narrower conditions

Ovarian Neoplasms (4)  ·  Colorectal Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Bone Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Carcinoma, Medullary (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Central Nervous System Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)

Broader conditions

Adnexal Diseases (4)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Neoplasms, Female (4)  ·  Gonadal Disorders (4)  ·  Neoplasms by Site (4)  ·  Ovarian Diseases (4)  ·  Urogenital Diseases (4)  ·  Neoplasms (3)  ·  Urogenital Neoplasms (3)  ·  Adenocarcinoma (2)

Interventions

Drug Therapy (1)  ·  Remote Patient Monitoring (1)

Sponsors

City of Hope Medical Center (1)  ·  Roswell Park Cancer Institute (1)  ·  SWOG Cancer Research Network (1)  ·  University of Southern California (1)

Countries

United States (4)  ·  Chile (1)  ·  Colombia (1)  ·  Mexico (1)

Top investigators

Emese Zsiros, MD, PhD (1)  ·  Kimberly Miller, PhD (1)  ·  Laleh Melstrom (1)  ·  Meghna S Trivedi (1)

NIH funding

P30CA014089 (1), P30CA033572 (1), P50CA159981 (1), R37CA256867 (1), UG1CA189974 (1)